Surface modification technologies to enhance the biocompatibility and performance of medical devices

Overview

Surface modification technologies have been successfully used for more than a decade across multiple device applications to reduce risk of thrombosis, bacterial adhesion and biofouling.

In this webinar, Jeannette Ho and Alexandra Piotrowicz, some of the core principal developers of the Endexo^® surface modification technology, share key tips on how medical device companies can enhance device functionality and biocompatibility while minimizing disruption to standard manufacturing processes and accelerating speed to market.

As a participant of this webinar you will learn about:

Patient risks for thrombus formation, bacterial adhesion and biofouling
Key polymer and manufacturing process compatibility requirements
How platforms require structural and chemical versatility to address specific application requirements
Clinical outcomes from customer studies with devices approved for cardiovascular and urinary applications

Experts featuring this session

Jeannette Ho
Senior Director Head of Surface Modification
Evonik Health Care
Vita

Jeannette Ho is a Senior Director at Evonik and leads our surface modification business. She joined Evonik in 2019 as part of the Company’s acquisition of the Endexo^® surface modification technology platform from Interface Biologics, a Canadian-based company. She co-founded Interface Biologics in 2001, where she held several senior positions including Director of R&D, Director of Operations and Vice President of Product Development. As part of the senior leadership team of Interface Biologics, Jeannette played a key role in the development and commercialization of the Endexo^® technology. She has extensive expertise across material science, polymer science, biomaterials, manufacturing processes, and medical device development, and holds a B.A.Sc. in Chemical Engineering from the University of Waterloo and a M.A.Sc. from the University of Toronto. Jeannette is the inventor on 12 patents, the author of 4 peer-reviewed publications, and is located in Toronto, Canada.

Alexandra Piotrowicz
Product Development Manager
Evonik Health Care

Related webinars in this series

This webinar is the third session of our 4-part webinar series on "Biomaterial solutions for implantable medical devices". For further details on the other three sessions please click on the respective webinar. To register for multiple sessions simply select them in the following registration form.